| Literature DB >> 34278012 |
Ningyu Lai1, Yuanchan Luo1, Peng Fei1, Peng Hu2, Hui Wu1,3,4.
Abstract
Syngas, which contains large amount of CO2 as well as H2 and CO, can be convert to acetic acid chemically or biologically. Nowadays, acetic acid become a cost-effective nonfood-based carbon source for value-added biochemical production. In this study, acetic acid and CO2 were used as substrates for the biosynthesis of 3-hydroxypropionic acid (3-HP) in metabolically engineered Escherichia coli carrying heterogeneous acetyl-CoA carboxylase (Acc) from Corynebacterium glutamicum and codon-optimized malonyl-CoA reductase (MCR) from Chloroflexus aurantiacus. Strategies of metabolic engineering included promoting glyoxylate shunt pathway, inhibiting fatty acid synthesis, dynamic regulating of TCA cycle, and enhancing the assimilation of acetic acid. The engineered strain LNY07(M*DA) accumulated 15.8 g/L of 3-HP with the yield of 0.71 g/g in 48 h by whole-cell biocatalysis. Then, syngas-derived acetic acid was used as substrate instead of pure acetic acid. The concentration of 3-HP reached 11.2 g/L with the yield of 0.55 g/g in LNY07(M*DA). The results could potentially contribute to the future development of an industrial bioprocess of 3-HP production from syngas-derived acetic acid.Entities:
Keywords: 3-Hydroxypropionic acid; Dynamic regulation; Escherichia coli; Metabolic engineering; Syngas-derived acetic acid
Year: 2021 PMID: 34278012 PMCID: PMC8255177 DOI: 10.1016/j.synbio.2021.06.003
Source DB: PubMed Journal: Synth Syst Biotechnol ISSN: 2405-805X
Fig. 1Simplified metabolic pathways of 3-HP biosynthesis by engineered E. coli strain using acetic acid as carbon source under aerobic condition. AcP, acetyl-phosphate; Ac-CoA, Acetyl-CoA; 3-HP, 3-hydroxypropionic acid; CIT, citrate; ICT, isocitrate, GOX, glyoxylate; α-KG, α-ketoglutarate; SucCoA, succinyl-CoA; SUC, succinate; FUM, fumarate; MAL, malate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate. ackA, acetate kinase; pta, phosphotransacetylase; acs, acetyl-CoA synthetase; acc, acetyl-CoA carboxylase; mcr, malonyl-CoA reductase; gltA, citrate synthase; aceA, isocitrate lyase; aceB, malate synthase; icdA: isocitrate dehydrogenase; sucAB, α ketoglutarate dehydrogenase; sucCD, succinyl-CoA synthetase; sdhABCD, succinate dehydrogenase; frdABCD, fumarate reductase; fumABC, fumarase; mdh, malate dehydrogenase; maeB, NADP-dependent malic enzyme; pckA, phosphoenolpyruvate carboxykinase; ppc phosphoenolpyruvate carboxylase; ppsA, phosphoenolpyruvate synthase; poxB, pyruvate oxidase; pykAF, pyruvate kinase; aceEF, pyruvate dehydrogenase complex; iclR, isocitrate lyase regulator; fabA, beta-hydroxyacyl-acyl carrier protein dehydratase/isomerase; fabB, beta-ketoacyl-acyl carrier protein synthase; fadR, fatty acid degradation repressor; Ptrc-mut, modified trc promoter.
Strains and plasmids used in this study.
| Strains/plasmids | Description | Source or reference |
|---|---|---|
| Strains | ||
| acetogenic bacterium | [ | |
| BL27 | MG1655 F-lambda- | From Prof Quan |
| LNY01 | BL27 P | This study |
| LNY02 | BL27 | This study |
| LNY03 | BL27 PR- | This study |
| LNY04 | BL27 P | This study |
| LNY05 | BL27 P | This study |
| LNY06 | BL27 Δ | This study |
| LNY07 | BL27 P | This study |
| BL27 (MDA) | BL27 containing pET28a-MDA | This study |
| BL27 (M*DA) | BL27 containing pET28a-M*DA | This study |
| LNY01(M*DA) | LNY01 containing pET28a-M*DA | This study |
| LNY02(M*DA) | LNY02 containing pET28a-M*DA | This study |
| LNY03(M*DA) | LNY03 containing pET28a-M*DA | This study |
| LNY04(M*DA) | LNY04 containing pET28a-M*DA | This study |
| LNY05(M*DA) | LNY05 containing pET28a-M*DA | This study |
| LNY06(M*DA) | LNY06 containing pET28a-M*DA | This study |
| LNY07(M*DA) | LNY07 containing pET28a-M*DA | This study |
| pKD4 | oriR6Kγ, KmR, | [ |
| pKD46 | [ | |
| pCP20 | ApR, CmR, FLP recombinance | [ |
| pBAD33 | Cloning vector, CmR, pACYC18 origin vector | Lab collection |
| pET28a- | KanR, pET-28a containing mutated | This study |
| pET28a-M*DA | KanR, pET-28a containing codon-optimized | This study |
| pET28a-MDA | KanR, pET-28a containing codon-optimized | [ |
Primers and promoters used in this study.
| Primers/promoters | Sequence ( |
|---|---|
| Primers | |
| F-delta- | TCTGGTATGATGAGTCCAACTTTGTTTTGCTGTGTTATGGAAATCTCACTCGTCTTGAGCGATTGTGTAG |
| R-delta- | AACAACAAAAAACCCCTCGTTTGAGGGGTTTGCTCTTTAAACGGAAGGGAGATGTAACGCACTGAGAAGC |
| F-P | AGTGCATGATGTTAATCATAAATGTCGGTGTCATCATGCGCTACGCTCTAGGCCTTTCTGCTGTAGGCTGG |
| R-P | TTCAGAACCAGTACTAACTTACTCGACATGGAAGTACCTATAATTGATACGGTCTGTTTCCTGTGTGAAAT |
| F–N940V(K1106W) | GTTTATTATCTGGCGGATCGCGTGGTTTCCGGCGAAACC |
| R–N940V(K1106W) | GCCATCAGACAGCGCAATCCAGCGCGCTACGCGAAAATG |
| F–S1114R | GCGCTGTCTGATGGCGCGCGTCTGGCGCTGGTAACC |
| R–S1114R | TTAAACGGTAATCGCGCGGCCGCGATGAATG |
| F- | ATCCGAATTCGAGCTCATGTCTGGTACCGGT |
| R- | GGTTTCGCCGGAAACCACGCGATCCGCCAGATAATAAAC |
| F- | AAGGATCCGTGTCAGTCGAGACTAGGAA |
| R- | GCAAGCTTTTACTTGATCTCGAGGAGAA |
| F- | GCGCTAGCATGACCATTTCCTCACCTTT |
| R- | ATGGATCCTTACAGTGGCATGTTGCCGT |
| TGTTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGACC | |
| P | TGTTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGTTAACGGTTAACAATTTCACACAGGAAACAGACC |
Fig. 2Profiles of cell density (A), acetic acid concentration (B), 3-HP concentration (C) and yield of 3-HP (D) in cultivation of different strains: BL27 (MDA), BL27 (M*DA), LNY01(M*DA), LNY02(M*DA), and LNY04(M*DA).
Fig. 5The 3-HP yield of different engineered strains.
Fig. 3Profiles of cell density (A), acetic acid concentration (B), 3-HP concentration (C) and yield of 3-HP (D) in cultivation of strain LNY03(M*DA) with different initial OD600 of induction: 1, 2.5, 3 and 4.
Fig. 4Profiles of cell density (A), acetic acid concentration (B), 3-HP concentration (C) and yield of 3-HP (D) in cultivation of different strains: LNY05(M*DA), LNY06(M*DA), and LNY07(M*DA).
Fig. 6Profiles of cell density, acetic acid and 3-HP concentrations in LNY07(M*DA) using whole-cell bioconversion of chemically synthesized acetic acid and syngas-derived acetic acid.